Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01039116 · ClinicalTrials.gov registry record · NA

Taking Action Together- A Diabetes Prevention Program

A NA study of Type 2 Diabetes, sponsored by University of California, Berkeley.

Completed
Registry status
NA
Development phase
240
Enrollment target
1
Study location

NCT01039116 is a NA study of Type 2 Diabetes that has completed, run by University of California, Berkeley. The registered enrollment target is 240 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01039116, a NA study of Type 2 Diabetes, has completed, sponsored by University of California, Berkeley.

COMPLETED
Registry status
NA
Development phase
240 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to determine whether once-weekly exposure to a program that fostered self-esteem building, and improvements in nutrition and physical activity behaviors would reduce risk of type 2 diabetes in overweight, inner-city, African American children when compared to a control group.

Conditions Studied

Interventions

  • BEHAVIORAL Low Intensity
  • BEHAVIORAL High Intensity

Study Locations (1)

California

  • YMCA of the East Bay, Oakland, CA 94612 - Oakland

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2005-03
Est. Completion 2009-12
Phase NA

Sponsor

University of California, Berkeley

72 total trials

What the Registry Record Tells You About NCT01039116

The ClinicalTrials.gov registry entry for NCT01039116 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (78% lower). The listed sponsor is University of California, Berkeley, which has 72 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Low Intensity is the first listed.

NCT01039116 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01039116 about?

NCT01039116 is a clinical study titled "Taking Action Together- A Diabetes Prevention Program". The purpose of this study was to determine whether once-weekly exposure to a program that fostered self-esteem building, and improvements in nutrition and physical activity behaviors would reduce risk of type 2 diabetes in overweight, inner-city, African American children when compared to a control ...

What is the current status of trial NCT01039116?

This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2005-03. Estimated completion is 2009-12.

What conditions does trial NCT01039116 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT01039116?

The interventions under investigation include: Low Intensity (BEHAVIORAL), High Intensity (BEHAVIORAL).

Who is sponsoring clinical trial NCT01039116?

This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01039116 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.